|
[1]
|
Hu, E., Weiss, L., Warnke, R. and Sklar, J. (1987) Non-Hodgkin’s Lymphoma Containing Both B and T Cell Clones. Blood, 70, 287-292. [Google Scholar] [CrossRef]
|
|
[2]
|
Trimech, M., Letourneau, A., Missiaglia, E., De Prijck, B., Nagy-Hulliger, M., Somja, J., et al. (2021) Angioimmunoblastic T-Cell Lymphoma and Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Novel Form of Composite Lymphoma Potentially Mimicking Richter Syndrome. American Journal of Surgical Pathology, 45, 773-786. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Thirumala, S., Esposito, M. and Fuchs, A. (2000) An Unusual Variant of Composite Lymphoma: A Short Case Report and Review of the Literature. Archives of Pathology & Laboratory Medicine, 124, 1376-1378. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Jin, X., Liu, H., Li, J., et al. (2023) Composite B-Cell and T-Cell Lymphomas: Clinical, Pathological, and Molecular Features of Three Cases and Literature Review. Journal of Zhejiang University: Science B, 24, 711-722. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Kim, H., Hendrickson, M.R. and Dorfman, R.F. (1977) Composite Lymphoma. Cancer, 40, 959-976. [Google Scholar] [CrossRef]
|
|
[6]
|
Küppers, R., Dührsen, U. and Hansmann, M. (2014) Pathogenesis, Diagnosis, and Treatment of Composite Lymphomas. The Lancet Oncology, 15, e435-e446. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Trecourt, A., Donzel, M., Fontaine, J., Ghesquières, H., Jallade, L., Antherieu, G., et al. (2022) Plasticity in Classical Hodgkin Composite Lymphomas: A Systematic Review. Cancers, 14, Article 5695. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Montoto, S. and Fitzgibbon, J. (2011) Transformation of Indolent B-Cell Lymphomas. Journal of Clinical Oncology, 29, 1827-1834. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Alaggio, R., Amador, C., Anagnostopoulos, I., Attygalle, A.D., Araujo, I.B.d.O., Berti, E., et al. (2022) The 5th Edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms. Leukemia, 36, 1720-1748. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Mendoza, H., Tormey, C.A., Rinder, H.M., Howe, J.G. and Siddon, A.J. (2021) The Utility and Limitations of B-and T-Cell Gene Rearrangement Studies in Evaluating Lymphoproliferative Disorders. Pathology, 53, 157-165. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Attygalle, A.D., Kyriakou, C., Dupuis, J., Grogg, K.L., Diss, T.C., Wotherspoon, A.C., et al. (2007) Histologic Evolution of Angioimmunoblastic T-Cell Lymphoma in Consecutive Biopsies: Clinical Correlation and Insights into Natural History and Disease Progression. American Journal of Surgical Pathology, 31, 1077-1088. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Zettl, A., Lee, S., Rüdiger, T., Starostik, P., Marino, M., Kirchner, T., et al. (2002) Epstein-Barr Virus-Associated B-Cell Lymphoproliferative Disorders in Angioimmunoblastic T-Cell Lymphoma and Peripheral T-Cell Lymphoma, Unspecified. American Journal of Clinical Pathology, 117, 368-379. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Brice, P., de Kerviler, E. and Friedberg, J.W. (2021) Classical Hodgkin Lymphoma. The Lancet, 398, 1518-1527. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Guo, R., Liang, J.H., Zhang, Y., Lutchenkov, M., Li, Z., Wang, Y., et al. (2022) Methionine Metabolism Controls the B Cell EBV Epigenome and Viral Latency. Cell Metabolism, 34, 1280-1297.E9. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Mainou, B.A., Everly, D.N. and Raab-Traub, N. (2007) Unique Signaling Properties of CTAR1 in Lmp1-Mediated Transformation. Journal of Virology, 81, 9680-9692. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Edwards, R.H., Marquitz, A.R. and Raab-Traub, N. (2015) Changes in Expression Induced by Epstein-Barr Virus LMP1-CTAR1: Potential Role of bcl3. mBio, 6, e00441-15. [Google Scholar] [CrossRef] [PubMed]
|